Trial Profile
A trial of Intravitreal injection of ranibizumab for treatment of age-related macular degeneration
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- 07 Dec 2015 New trial record